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Summary  
Gastrointestinal resections are a common operation and most involve an 
anastomosis to re-join the ends of the remaining bowel to restore gastrointestinal 
(GIT) continuity. While most joins heal uneventfully, in up to 26% of patients healing 
fails and an anastomotic leak (AL) develops. Despite advances in surgical 
technology and techniques, the rate of anastomotic leaks has not decreased over 
the last few decades raising the possibility that perhaps we do not yet fully 
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understand this phenomenon of AL and are thus ill-equipped to prevent it. As in all 
complex conditions it is necessary to isolate each different aspect of disease for 
interrogation of its specific role, but, as we hope to demonstrate in this article, it is a 
dangerous oversimplification to consider any single aspect as the full answer to the 
problem. Instead, consideration of important individual observations in parallel could 
illuminate the way forward toward a possibly simple solution amidst the complexity. 
This article details three aspects that we believe intertwine, and therefore should be 
considered together in wound healing within the GIT, during post-surgical recovery: 
the microbiome, the host genetic makeup, and their relationship to the peri-operative 
inflammatory status. Each of these, alone or in combination, has been linked with 
various states of health and disease, and in combining these three aspects in the 
case of post-operative recovery from bowel resection, we may be nearer an answer 
to preventing anastomotic leaks than might have been thought just a few years ago.  
 
Introduction 
Treatments for haemorrhoids have been described since the 12th and 13th century 
BC, but direct surgical intervention in other parts of the bowel was actively avoided in 
ancient times, being performed infrequently even in acute injuries, and almost 
always ending dismally [1]. It was only in 1783 that Dubois performed the first 
recorded operation on uninjured bowel in the form of a colostomy for anorectal 
malformation in a baby, who survived only ten days [2].  Another forty years would 
pass before the first successful segmental colonic excision was performed in 1823, 
but this was followed soon after by a successful anorectal excision in 1826 [3]. Since 
then, the numbers of lower gastrointestinal tract (GIT) operations have grown 
exponentially, alongside refinements in operative technique and technology. In the 
UK alone, between 2005-2014, traditional open surgery for colonic resections 
persisted at approximately 25 000 per annum, yet in addition, laparoscopic 
resections increased sevenfold to over 7 000 cases in 2014 [4]. The rising number of 
lower GIT resections comes as no surprise due to increased public awareness of 
symptoms of bowel pathology, in combination with screening programmes performed 
in an ageing population. Reassuringly, improvements in survival have been 
substantial compared to that first foray into GIT surgery in the 18th century. But one 
complication continues to haunt the surgeon, and indeed, the surviving patient: the 
anastomotic leak (AL).  
Many resections now involve an anastomosis to re-join the ends of the remaining 
bowel, thus restoring GIT continuity. While most heal uneventfully, in up to 26% of 
patients [5] healing fails and an anastomotic leak (AL) develops despite the best 
technical efforts. When an anastomotic leak occurs, intestinal contents leak into the 
peritoneal cavity. Intestinal contents contain multiple microorganisms and either 
digestive enzymes or frank faeces, depending on the location of the anastomosis 
within the GIT. This can result in a range of complications such as abscesses, erosion 
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of surrounding tissues causing abnormal connections (fistulae), generalised infection 
of the peritoneum (peritonitis) with an accompanying systemic inflammatory response, 
and even multi-organ failure and death. Because of the serious consequences of 
failure of healing, decades have been dedicated to optimising operative techniques 
such as accurate apposition of tissues with submucosal suturing to evert the mucosal 
layer for a leak-free join, careful preservation of the vascular arcades to the ends of 
the anastomosis with visible perfusion, and maintenance of a sterile operating field. 
When these failed to eliminate leaks, further fine-tuning extended to the peri-operative 
period with careful control of blood pressure and albumin levels, in addition to 
advances in surgical technology resulting in staplers, fibrin glue and nickel-titanium 
compression ring anastomotic techniques [6]. But none of these have proven 
infallible. For decades, surgeons have puzzled over this conundrum and searched for 
additional surgical or patient risk factors, such as smoking, male sex, anastomoses 
close to the anal verge, high arterial ligation or pre-operative radiotherapy [7–10]. 
Many risk stratification strategies have emerged but again, none consistently predict 
[11–13] or explain this often-catastrophic complication. Indeed, despite increasing 
sophistication in surgical and anaesthetic techniques, the rate of anastomotic leaks 
has not decreased over the last few decades [14]. This raises the possibility that 
perhaps we do not yet fully understand this phenomenon of ALs and are thus ill-
equipped to prevent it.  
So what do we know so far about the reasons anastomoses leak, and where might 
the future lie for research in this area? As in all complex conditions, it is necessary to 
isolate different aspects of disease for interrogation of its specific role, but, as we 
hope to demonstrate in this article, it is a dangerous oversimplification to consider 
any single aspect as the full answer to the problem. Instead, consideration of 
important individual observations in parallel could illuminate the way forward toward 
a possibly simple solution amidst the complexity. Literature directly related to 
molecular aspects of anastomotic healing is less extensive than would have been 
ideal, perhaps because there are technical challenges in creating an intestinal 
wound and subsequently directly observing healing in an internal organ in a clinically 
relevant manner. Also, it is only recently that the unique aspects of wound healing in 
the GIT distinct from that of other epithelial surfaces such as the skin or even lung 
are being recognised. This viewpoint article details three aspects that we believe 
intertwine, and therefore should be considered together in wound healing within the 
GIT, during post-surgical recovery: the microbiome, the host genetic makeup, and 
their relationship to the peri-operative inflammatory status (Figure 1).  
 
The role of inflammation 
One of the defining observations in early medicine was that inflammation 
accompanies injury. First described by Celsus in 1AD [15], the cardinal features of 
inflammation, to different magnitudes, inevitably follow invasive surgical procedures. 
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Many of the basic tenets of good surgical practice such as meticulously gentle tissue 
handling, preserving a good blood supply, debridement of non-viable tissue, and 
asepsis, may have their molecular basis in minimising the magnitude of inflammation 
that occurs. Whilst there is certainly no place for gross departure from these 
principles, how important are they in preventing AL and how might they relate to 
cellular and molecular aspects of inflammation?  
 
Many pharmacological and mechanical aspects have been reviewed [34] over the 
years and a selected few are summarised in Table 1. But interpretation of these 
experimental results is more complex than would seem at first glance. Let us 
examine, as an example, the importance of a good blood supply to the ends of the 
bowel forming the anastomosis. It almost defies common sense that anything could 
be more important than this. And yet experimental evidence is conflicting. Early 
experiments in dogs with intentional vascular occlusion causing 5cm of visible 
devascularisation of the anastomotic region showed that in the sterile bowel, 
maintained by intraluminal antibiotic treatment, anastomoses healed despite this 
ischaemia [16]. More recent examples in rodents with segmental colonic ischaemia 
at the sites of anastomoses suggested a lack of difference in levels of tissue hypoxia 
between healed or non-healed anastomoses [35]. However, in other studies using 
more severe arterial occlusion, positive effects with hyperbaric oxygen therapy 
(HBOT) have been demonstrated in healing, and negative effects with systemic 
hypoxia  [21,20]. In hypoxia, it appears logical that decreasing the partial pressure of 
available atmospheric oxygen would subsequently decrease the haemoglobin 
saturation, and thus push oxygen delivery below the threshold for wound healing in a 
situation of tenuous vasculature. Conversely, in hyperbaric oxygen therapy (HBOT), 
where 100% oxygen is given at higher than atmospheric pressure, not only are red 
blood cells fully saturated, but blood can become hyperoxygenated by plasma 
saturation as well, leading to possibly adequate oxygen delivery despite fewer 
vascular connections. 
But even if we suppose that perhaps the submucosal plexus of the intestine is more 
robust in animals and that experimental models do not adequately recapitulate 
human physiology, clinical reports also conflict. While reduced microperfusion of the 
rectal stump has been linked to ALs as might be expected [36], a separate 
histological study of microvessel density revealed no difference between AL and 
healed specimens [18]. This confusion surrounding the hierarchical importance of 
blood supply has not slowed efforts to improve intraoperative visualisation of 
perfusion, with innovations such as scanning laser Doppler flowmetry [37] and 
fluorescent indocyanine green (ICG) being introduced in recent years. But again, for 
example with ICG, there is still a lack of randomised controlled trials evidencing a 
significantly reduced AL rate [38]. Although non-randomised studies have indicated 
no leaks in the anastomoses that were immediately revised based upon 
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intraoperative ICG fluorescence, it is unknown if these would ultimately have leaked 
without revision [39].  
Perhaps some of the difficulties in obtaining a clear-cut conclusion are because the 
hypoxia-inflammation axis is more complex within the bowel, compared to other 
mucosal surfaces like the lung. The bowel is unique in that highly vascularised 
intestinal structures are in proximity to a physiologically hypoxic lumen especially 
within the lower GIT [40]. Studies in dogs suggest the existence of a counter current 
flow within small intestinal villi which allows this permissive hypoxia [41], although 
there is absence of evidence for this in other mammals such as the rat [42], and the 
picture is complicated by fluctuations in blood flow from post-prandial hyperaemia. 
But within the colon, where post-prandial hyperaemia has not been demonstrated, 
the steep hypoxic gradient appears to be maintained by subsets of facultative 
anaerobes residing close to the mucosa [43]. In line with this gradient, the GIT is well 
adapted to tolerate hypoxia and intestinal epithelial cells express the three hypoxia-
inducible factor (HIF) Į subunits and the constitutive HIF-1ȕ subunit that completes 
the heterodimer, as well as their inhibitors, the three prolyl hydroxylases (PHDs) and 
factor-inhibiting HIF1 (FIH1) [44]. Under basal conditions of physiologic hypoxia, HIF-
1Į is stabilised and, as a transcription factor, serves to perform enhanced barrier 
integrity functions in the gut by increasing expression of a multitude of genes such as 
those coding for mucin [45] and antibacterial peptide production [46]. As oxygen 
becomes plentiful, PHDs hydroxylate the inducible Į subunit and target it for 
degradation. So central is the role of HIF1 in maintenance of mucosal homeostasis 
that inhibitors of PHDs are being trialled clinically as treatment for the chronic 
inflammatory states of Crohn’s Disease and Ulcerative Colitis [47,48].  
It is well established that the early stages of inflammation involve an influx of innate 
immune cells, neutrophils followed by macrophages, which patrol the inflamed area 
removing debris and invading pathogens. Neutrophils are primarily glycolytic [49] 
and therefore able to function without detriment in environments of low oxygen 
tension. However, neutrophils also increase hypoxia in inflammatory environments 
as they consume many more times the amount of oxygen than other cells, when 
generating an antimicrobial oxidative burst [50]. Whilst it might be imagined that 
hyperbaric oxygen therapy (HBOT) in the animal experiments above acts solely by 
reversing this hypoxia, the picture is more complex. HBOT in fact also acts in an 
anti-inflammatory manner within the intestine, and has been shown to directly block 
interleukin-1ȕ (IL-1ȕ) and increase HIF-1Į mRNA [51]. This is possibly through 
stabilisation of HIF-1Į via formation of oxygen radicals, but exact mechanisms are as 
yet unclear [51]. Other studies of HBOT in the acute inflammatory process also 
demonstrate a down-regulation of cyclooxygenase-2 (COX2) mRNA [52], 
highlighting the anti-inflammatory role of this therapy. A similar example of the 
complexity of mechanism of action is with sildenafil, a vasodilator beneficial in 
anastomotic healing [53], but which also has independent anti-inflammatory 
properties, decreasing TNF-Į and interleukin-6 (IL-6) in human studies [54]. The 
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effect of inflammation is also important in other areas that may indirectly impact upon 
healing. One example is that of post-operative ileus, where normal GIT motility fails 
to return in a timely manner. The sympathetic neural response to intrusion of the 
peritoneal cavity and handling of bowel causes a reactive hypomotility of the GIT, 
which usually fades quickly upon abdominal closure, but prolonged ileus can occur, 
has been shown to be associated with increased IL-6 and leukocyte infiltration of the 
bowel [55,56], and has a positive correlation with rates of AL [57]. Here again 
evidence shows that inhibiting the inflammatory axis via COX-2 improves ileus 
[58,59]. Some clinical studies comparing laparoscopic with open surgery suggest a 
relationship between decreased inflammation, as evidenced by a lower CRP level 
post-laparoscopy, with lower ileus and AL rates [60], but caution needs to be 
exercised in interpreting these results as correlation does not always imply 
causation.      
Indeed, eliminating inflammation per se does not seem to be a panacea because, 
paradoxically, anti-inflammatory drugs have met with unexpected failure in 
preventing ALs. Although prescribed mainly for analgesia rather than reduction of 
inflammation, NSAIDs  are associated instead with an increase in AL [61,62]. This 
may be because, while COX-1 is constitutively expressed by intestinal epithelial 
cells, COX-2 expression is initiated by the presence of inflammatory mediators. 
Recent studies in mice have identified COX-2 dependent production of PGE2 as 
essential for neovascularisation and subsequent intestinal healing, with disruption of 
this pathway increasing ALs [63]. Other inflammatory mediators such as IL-6 have 
also been shown to be essential during the initial injury phase to promote epithelial 
reconstitutition within the intestine [64]. Certainly sound surgical technique cannot be 
sacrificed for molecular nuances, but what on the surface may appear to be due 
merely to sensible surgical technique may be much more complex than previously 
thought.   
Interestingly, in the experiments above, administration of PGE2 alone did not fully 
rescue the COX-2 knockout AL phenotype [63]. As the authors suggest, this could 
be due to dosage, since in mice there appears to be a high sensitivity to the loss of 
even one functional allele of the parent gene [65], or perhaps due to the lack of other 
eicosanoids such as PGI2 or specialised pro-resolving mediators such as lipoxins 
and resolvins. But there is also evidence that TLR4 and MyD88 signalling pathways, 
central in host-pathogen interactions, are required for optimal tissue repair in 
intestinal wounds [66]. All these reinforce the suggestion that the pathways of 
inflammation and healing are complex and closely intertwined, particularly in the 
context of the GIT where there is a close presence of a multitude of microbes, such 
that it becomes difficult to tease out the dominant (if any) pathway leading to a 
beneficial or detrimental effect. In the example of HBOT, not only are anti-
inflammatory pathways activated, but the increased pressure of oxygen perturbs the 
hypoxic gradient of the intestine and alters the composition of up to 29 species of 
bacteria within the rodent intestine [43]. This has the potential for wide-ranging 
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consequences, since the inflammatory responses are also primed by the intestinal 
microbiome. A study comparing the inflammatory responses of germ-free (Gf) and 
conventional mice to LPS and ischaemic injury showed that Gf mice had a 
significantly increased lipoxin-induced production of IL-10 and a dampened 
inflammatory response [67]. Similarly, over half a century ago, post-operative ileus 
itself was shown to improve with administration of antibiotics [68]. So could the 
traditional thinking of complete eradication of microbiota to minimise surgical site 
infections also ameliorate ALs? 
 
The role of the intestinal microbiome 
The field of microbiomics has rapidly expanded in recent years with sequencing 
techniques that allow identification of non-culturable bacteria [69]. The identification 
of this vast community of microbiota quickly led to demonstration of the 
consequences of intestinal microbiota in diseases once thought to be far removed 
and distinct from the gut, such as hypertension [70] and Parkinson’s Disease [71]. 
But as interactions between distant systems are increasingly uncovered, interest in 
the relevance of gut microbiota closer to home, within the GIT itself, has also had a 
revival with excellent reviews published suggesting an important role for microbiota 
in wound healing in surgery and also in GIT cancers [72–75]. Intestinal antisepsis is 
not a new concept in GIT surgery particularly in the lower GIT which harbours the 
highest concentration of bacteria within the human body under conditions of health. 
Antibiotics were used in colorectal surgery as early as 1938, and since the work of 
Poth, Cohn and Cohen [73,76], it is now widely accepted that intestinal microbes 
play important roles in ALs.  
We know that although the core milieu of microbiota within the GIT persists stably in 
an individual [77], it is still changeable and alters over time with age [78], and within 
hours to dietary and lifestyle changes such as exercise, smoking [79–81] and indeed 
surgery. Experiments in rats demonstrated a 500-fold increase in Enterococcus and 
200-fold increase in Eschericaea, in conjunction with a 20-fold decrease in 
Ruminococcacea, Clostridia and Prevotellaceae [82] following a surgical procedure. 
A similar change was demonstrated in human patients undergoing a colectomy, 
again with an increase in Enterobacteriacaea, Enterococcus, Staphylococcus, and 
Pseudomonas (an aerobe), and a decreased in obligate anaerobes like 
Bifidobacterium [83].  
These changes are of particular interest since Enterococcus faecalis is potentially 
directly responsible for ALs by degrading collagen through expression of gelatinase 
E [84]. Emerging evidence also suggests that prior radiotherapy, as is commonly 
used for some rectal cancers, may cause mutations in bacteria such as 
Pseudomonas that increase bacterial virulence. In a rat model of rectal surgery, pre-
treatment with radiotherapy in the presence of Pseudomonas significantly increased 
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ALs due to a mutation increasing pyocyanin and collagenase activity [85]. This was 
in clear contrast to the complete lack of ALs in rats who underwent radiotherapy and 
an anastomosis but were free of Pseudomonas. These appear to be compelling 
pieces of evidence that eradication of microbiota may hold the key to ameliorating 
ALs; so much so that a recent summary of clinical trials to date [73] concluded that 
routine bowel preparation with non-absorbable antibiotics should be recommended. 
But could it be that the resultant significant changes in intestinal microbiota, as would 
be the case even for narrow spectrum antibiotics, may cause more harm than good 
both in the short and long term? It is indisputable that prolonged and repeated 
courses of antibiotics and polypharmacy [86,87] influence the long-term diversity of 
the microbiome, but even a single pulse of broad spectrum antibiotics in mice appear 
to cause long term microbiome changes [88] which ultimately have the potential to 
negatively impact later physical health (such as growth, diabetes and obesity), 
mental health [89–91] and even mortality [86,92]. 
It is in fact quite impossible to eradicate intestinal microbiota in its entirety, because it 
would be necessary to ensure that the chosen antibiotic would be able to reach and 
eradicate both autochthonous (resident) microbes and not just allochthonous 
(luminal transient) microbes throughout the length of the GIT. Even then, such an 
action would be undesirable since the risk remains that dormant spores such 
Clostridium difficile might reactivate causing serious disease [93]. But quite apart 
from that, evidence is accumulating that the presence of the microbiome may be 
beneficial, and even necessary, for optimal wound healing, in addition to its other 
whole organism effects. In vitro studies have shown that Akkermansia muciniphila 
and Bacteroides fragilis significantly improved gut epithelial integrity, and furthermore 
survive normoxic conditions despite being anaerobes [94], an important 
consideration since exposure to environmental oxygen during a surgical resection 
temporarily increases oxygen tension within the lower GIT and diminishes obligate 
anaerobes. These bacterial effects have been replicated in vivo in mice with 
encouraging results showing accelerated mucosal re-epithelialisation [95,96]. 
Conversely, a lag in skin wound healing in Gf guinea pigs has been noted from 
experiments in the 1960s [97], with similar findings of a lower tensile strength of 
intestinal anastomoses in Gf mice [98,99].  
But in addition to the positive effects on wound healing, it is increasingly recognised 
that intestinal microbiota are directly implicated in the proper development of the 
immune system. The presence of intestinal commensals is vital in the development 
of gut-associated lymphoid tissues, secretory IgA, and Th17 cells, a subset of T-
helper cells important in inflammation [100,101]. But, as mentioned previously, the 
importance of microbiota does not end in development. Throughout life, the 
microbiome continues to exert a tonic effect on the inflammatory response. 
Supplementing Bifidobacteria to post-operative patients decreased pro-inflammatory 
cytokines and enhanced recovery [102], and the gut commensal Faecalibacterium 
prausnitzii orchestrates anti-inflammatory effects by inducing secretion of IL-10 and 
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reducing IL-12 and IFNڜ [103]. Even a single factor, Polysaccharide A from 
Bacteroides fragilis, is able to induce production of IL-10 and confer protection from 
experimental colitis in animal models [104]. 
Furthermore, in all discussions of antimicrobials, it is of vital importance to remember 
that it is not only bacteria that make up the intestinal -biomes. Fungal, archaea, and 
viral entities also co-exist [105,106], and their roles have yet to be fully explored in 
the pathogenesis of a multitude of conditions. It was only two years ago that a study 
demonstrated an increased fungal load in the chronically inflamed intestines of 
Crohn’s patients [107] even though fungi have been identified in the GIT for over a 
century [108]. Over the past decade, experiments in rodents have identified a rich 
mycobiome that exists alongside the microbiome, and which similarly influences 
health and disease. Mice lacking the innate immune receptor Dectin-1, which is also 
a fungal signalling receptor, are highly susceptible to severe colitis, paralleling 
observations in humans [109], suggesting that fungal presence may add some 
benefit to the overall homeostasis of the GIT. 
Although yet to be demonstrated specifically in anastomotic wounds, evidence also 
exists that fungal pathogenicity increases with antibacterial therapy, and are 
implicated in necrotic or non-healing wounds [110]. Interestingly, within the intact gut 
of the worm, Candida albicans and Enterococcus faecalis show a symbiotic 
relationship, concurrently reducing the pathogenicity of the other. In the absence of 
Enterococcus faecalis, Candida albicans showed an increased hyphal 
morphogenesis, a key virulence factor [111]. This type of relationship is not limited to 
the GIT. Even in the skin, co-colonisation of pathogenic Staphylococcus aureus with 
the commensal, Corynebacterium striatum, caused a down regulation of 
Staphylococcal haemolysin activity and a shift toward commensalism [112]. And in 
the urinary tract, escherichelin production by Enterobacteriae cause an inhibition of 
growth of Pseudomonas by competitive inhibition of iron transport [113]. These 
examples should serve to promote caution in advocating blanket antimicrobials for 
the removal of any one species of bacteria shown to be responsible for ALs within 
the highly regulated environment of an animal facility, since the results may not be 
quite as straightforward in real-world human cases 
Whilst evidence is mounting that the composition of intestinal microbiota is vital in 
determining the final outcome of an anastomosis and that it is eminently malleable 
by exogenous supply or by dietary and antimicrobial manipulations, it would be 
rather difficult to ensure the ideal mixture of microbes for perfect wound healing be 
present through standardised prescriptions. This is especially so since inter-
individual variation is substantial and it is not yet fully understood how an individual 
selects or maintains the composition of their personal microbiome. This continues to 
be an area of active research, but already it is emerging that genetic variation is one 
of the key factors in controlling inflammatory responses to the same microbial 
stimulus [114] and possibly the resulting dysbiosis associated with various illnesses. 
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The role of the host genetic makeup 
The inflammatory response to injury and infection has to be carefully controlled to 
avoid disease states. Classical eicosanoids, docosanoids, as well as the newer 
bioactive lipid mediators play important roles in this process. But whilst knowledge is 
increasing in these areas, the pathways remain highly complex, having a dynamic 
expression that is dependent on many factors such as time, tissue specificity and 
cell-cell interactions [115]. This makes it challenging to isolate the effects of inhibiting 
a single pathway, since knock-on effects on other pathways are often present and 
not always predictable particularly in the early stages. The lipid signalling and 
metabolism pathway starts with a supply of arachidonic acid liberated by the 
phospholipase A2 enzyme, and Ȧ-6 and Ȧ-3 polyunsaturated fatty acids (PUFAs). 
These are then further modified by cyclooxygenase (COX), lipoxygenase (LOX) or 
cytochrome p450 (CYP) enzymes [115] into many different end products. Over the 
past decade, the importance of these lipid pathways in human disease has been 
investigated in some detail [116]. Although the primary end-point in many of these 
studies was cancer, they remain relevant because of implications for the role of 
inflammation, which has been shown to have both a cell-autonomous and non-cell-
autonomous function in promotion of carcinogenesis [117]. Epidemiological studies 
show that up to 20% of cancers are the direct result of chronic inflammation [118], 
and over the past century, tumour initiation, maintenance and progression has been 
proven to have clear molecular similarities with the non-healing wound [119–121], 
and a strong association with the prevailing microbial landscape [122]. Therefore 
polymorphisms in pathways found to be important in cancer prevention or 
development are also likely to be important in prevention of or predisposition to ALs. 
Humans are unable to convert Ȧ-6 PUFAs into Ȧ-3 PUFAs and therefore the 
availability of each in the diet corresponds to its abundance within the body thus 
facilitating epidemiological studies. Cohort studies with manipulation of the 
exogenous supply of each (Ȧ-6 in excess being pro-inflammatory and Ȧ-3 anti-
inflammatory) have been performed, which were then correlated to cancer risk. 
Results of these early studies have been contradictory and overall failed to 
definitively associate a reduction in sporadic forms of cancer with increased Ȧ-3 
PUFA consumption. These equivocal results can partly be explained by newly 
discovered single nucleotide polymorphisms (SNPs) within the COX genes, such 
that only those with a pro-inflammatory COX1 variant derived benefit from Ȧ-3 
supplementation [123]. The converse is also true, albeit shown in a distinct Chinese 
population, with pro-inflammatory COX2 polymorphisms conferring elevated risk 
when combined with increasing Ȧ-6 PUFA consumption [124].  
Multiple experimental and clinical studies have investigated links between various 
non-genetic aspects thought to be important in anastomotic healing and in many 
cases results have not been immediately clear, or have even been conflicting. Given 
similar difficulties described above  with establishing cause-and-effect in PUFAs and 
cancer, it is likely that subtle genetic differences in these pathways also underlie 
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susceptibility to ALs. Some progress has been made to identify genetic differences in 
post-operative complications such as pneumonia, once thought to be mainly due to a 
mechanical effect of reduced inspiratory depth following a laparotomy, but where an 
IL-10 polymorphism has been shown to be an independent risk factor [125]. Various 
cytokine polymorphisms have also been implicated as risk factors in the 
development of severe sepsis [126], but strong links specifically to ALs is still in its 
infancy.  We speculate that future work would be likely to show the central 
importance of these pathways of inflammation in ALs. 
 
For example, while a low anastomosis has been identified as a risk factor for ALs [7–
10], the molecular explanation for this has been somewhat elusive. But perhaps the 
answer lies in the genetic predisposition of the patient. A SNP in PTGS2 (−765G>C; 
rs20417) resulting in decreased COX2 expression has been strongly associated with 
the risk of developing rectal cancer but not colon cancer [127]. And as mentioned 
previously, COX2 plays a vital early role in promoting the angiogenesis important for 
anastomotic healing. This could be an explanation for the increased leak rate in 
rectal cancer surgery compared to colonic cancer surgery. Similarly, SNPs in the 
LOX pathways, for example that of lipoxygenase-15 (ALOX15 1351G>A), has been 
positively associated with the risk of rectal, and not colon, cancer [128]. Since the 
products of ALOX15 such as the lipid mediator lipoxin A4 are also  mediators of 
inflammation resolution, this hints at yet another subtle but important role of host 
genetics on inflammation and an increased risk of ALs. Thus far, a single study has 
identified a link between homozygosity in the PTGS2 SNP conferring rectal cancer 
risk and an increased risk of ALs, even though a distinction between colon or rectal 
resections was not made [63]. But the complexity of this area of research is 
exemplified by the knowledge that the prevalence of this polymorphism is only 3% 
[129], it is not the only polymorphism of significance, and differences may be present 
in accordance with ethnicity [130].  
 
Conclusion 
It is an exciting time for researchers in this field as significant progress is being made 
in each of the three fundamental areas that ultimately converge for bowel healing. It 
is clear that there still remains work to be done to unite these areas in our 
understanding of the molecular underpinnings of ALs. While it is still early days for 
investigation of genetic polymorphisms in post-operative complications, it is an area 
likely to be extremely complex due to the vast possibilities of candidate genes if 
assessed independently. But it seems likely that, for the future, the most productive 
translational impact will necessarily be found in integrating all three aspects to drive 
the field forward with personalised therapeutic options based upon the genetic 
predisposition of the patient. The complexity of GIT homeostasis dictates that, while 
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it is certainly helpful to dissect molecular targets and pathways by investigating 
isolated aspects, it is vital that all three fundamental areas be considered together in 
order to make a meaningful step toward translational therapeutic strategies to 
prevent the dreaded complication of ALs once and for all.  
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Table 1: Exemplar interventions for prevention of ALs and their relationship to the 
inflammatory process. This list includes some of the options that have been 
investigated, how they might ultimately impact upon the inflammatory pathways, and 
their often divergent conclusions. 
Intervention 
investigated 
Relationship to the 
inflammatory process 
Author/Year Conclusion 
Ischaemia prevention PHD/HIF pathways (see text)
 
 
Cohn&Rives 
1956[16] 
 
 
Shaksheer et al 2016 
[17] 
 
  
Schouten et al 
2014[18] 
 
 
 
Pommergaard et al 
2015 [19] 
 
 
Attard et al 2005[20] 
 
 
 
Boersema et al 2016 
[21] 
 
 
Ischaemia did not 
cause AL in a sterile 
bowel in dogs 
 
No difference in 
tissue hypoxia 
levels in mice 
 
No differences in 
microvessel density 
in human histology 
specimens 
 
Impaired blood 
supply impairs 
healing in mice 
 
Systemic hypoxia 
impairs healing in 
rats 
 
HBOT improves 
anastomotic 
healing in rats 
 
Electromagnetic field 
therapy (EMF) 
Electromagnetic field therapy 
can downregulate 
inflammatory cytokines (IL6, 
IL1 COX2) and upregulate 
IL10 [22,23]  
 
Mente et al 1996 
[24] 
 
 
 
 
 
Nursal et al  2001 
[25] 
Improved 
mechanical 
strength and 
hydroxyproline 
content  with EMF 
in mice 
 
No difference in 
mice 
 
Amniotic membrane Amniotic membranes have 
integral immunomodulatory 
properties to avoid rejection 
of foetus 
 
Barski et al 2016 [26]
 
 
 
 
Moslemi et al 2016 
[27] 
Increased 
inflammation and 
adhesion, does not 
prevent AL in mice 
 
Prevents AL and 
reduced adhesions 
in rats 
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Fibrin glue/sealants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mechanical barrier reducing 
perianastomotic  
Inflammation 
Pantelis et al 2010 
[28] 
 
 
Senol et al 2012 [29] 
 
 
 
 
Nordentoft et al 
2015 [30] 
 
 
Slieker et al 2013 
[31] 
 
 
Positive effect with 
fibrin glue in 
healing in mice 
 
Improved 
hydroxyproline 
content with fibrin 
glue in rats 
 
A review showing 
lack of effect of 
fibrin glue 
 
No effect of six 
different sealants 
in mice 
 
Sildenafil Decreased neutrophil 
infiltration/decreased 
cytokine (see text) 
Cakir et al 2015 [32]
 
 
Irkorucu et al  2009 
[33] 
Improved collagen 
maturity in rats 
 
No effect on 
anastomotic 
integrity in rats  
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Figure 1: Surgical resection and anastomosis of the bowel (A) where wound healing 
is influenced by three interdependent factors: host genetic susceptibility, 
inflammatory response, and the existing intestinal microbiome. The interaction of 
these three factors leads either to A. healing of anastomosis with epithelial 
restitution, resolved inflammatory responses, restored mucous barriers and microbial 
homeostasis; or to B. failed healing leading to an anastomotic breakdown, leakage of 
intestinal contents, bacterial translocation and systemic sequela. Graphs adapted 
from Clarke, RAF (1996) The molecular and cellular biology of wound repair. 
 
 
 
 
 
 
 
 
